Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-09-19

FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Original Application (Nivagen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved the original ANDA for a generic dexmethylphenidate hydrochloride product manufactured by Nivagen Pharmaceuticals, Inc., for the treatment of attent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXMETHYLPHENIDATE HYDROCHLORIDE (dexmethylphenidate hydrochloride)

Snippet

ORIG AP for DEXMETHYLPHENIDATE HYDROCHLORIDE (DEXMETHYLPHENIDATE HYDROCHLORIDE)